首页>
外国专利>
USE OF HUMAN HEMOKININ-1 AND OPTIONALLY OXYTOCIN TO TREAT DISEASES INVOLVING EXCESSIVE ANGIOGENESIS
USE OF HUMAN HEMOKININ-1 AND OPTIONALLY OXYTOCIN TO TREAT DISEASES INVOLVING EXCESSIVE ANGIOGENESIS
展开▼
机译:使用人类血红素-1和可选的催产素治疗涉及过度血管生成的疾病
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention is directed to the use of the peptide compound Thr-Gly-Lys-Ala- Ser-Gln-Phe-Phe-Gly-Leu-Met-NH2 as a therapeutic agent for the prophylaxis and/or treatment of cancer, autoimmune diseases, fibrotic diseases, inflammatory diseases, neurodegenerative diseases, infectious diseases, lung diseases, heart and vascular diseases and metabolic diseases. Moreover the present invention relates to pharmaceutical compositions preferably in form of a lyophilisate or liquide buffer solution or artificial mother milk formulation or mother milk substitute containing the peptide Thr-Gly-Lys-Ala-Ser-Gln-Phe-Phe-Gly- Leu-Met-NH2 optionally together with at least one pharmaceutically acceptable carrier, cryoprotectant, lyoprotectant, excipient and/or diluent.
展开▼